🇺🇸 Gonadotropins in United States

39 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Caesarean Section — 5 reports (12.82%)
  2. Drug Exposure During Pregnancy — 5 reports (12.82%)
  3. Ectopic Pregnancy — 5 reports (12.82%)
  4. Exposure During Pregnancy — 5 reports (12.82%)
  5. Ovarian Hyperstimulation Syndrome — 5 reports (12.82%)
  6. Abdominal Pain — 3 reports (7.69%)
  7. Drug Exposure Before Pregnancy — 3 reports (7.69%)
  8. Haemorrhage — 3 reports (7.69%)
  9. Platelet Count Decreased — 3 reports (7.69%)
  10. Anxiety — 2 reports (5.13%)

Source database →

Gonadotropins in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in United States

Frequently asked questions

Is Gonadotropins approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Gonadotropins in United States?

University of Athens is the originator. The local marketing authorisation holder may differ — check the official source linked above.